DE10399037I2 - Rekombinante Virusproteine begleitet von lymphadenopathischem Sydrom und/oder "Acquired Immune Deficiency Syndrome" (AIDS). - Google Patents
Rekombinante Virusproteine begleitet von lymphadenopathischem Sydrom und/oder "Acquired Immune Deficiency Syndrome" (AIDS).Info
- Publication number
- DE10399037I2 DE10399037I2 DE2003199037 DE10399037C DE10399037I2 DE 10399037 I2 DE10399037 I2 DE 10399037I2 DE 2003199037 DE2003199037 DE 2003199037 DE 10399037 C DE10399037 C DE 10399037C DE 10399037 I2 DE10399037 I2 DE 10399037I2
- Authority
- DE
- Germany
- Prior art keywords
- lymphadenopathic
- sydrome
- aids
- recombinant virus
- immune deficiency
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/108—Plasmid DNA episomal vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/005—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination repressible enhancer/promoter combination, e.g. KRAB
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/15—Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/36—Vector systems having a special element relevant for transcription being a transcription termination element
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/55—Vector systems having a special element relevant for transcription from bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/70—Vector systems having a special element relevant for transcription from fungi
- C12N2830/702—Vector systems having a special element relevant for transcription from fungi yeast
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/70—Vector systems having a special element relevant for transcription from fungi
- C12N2830/702—Vector systems having a special element relevant for transcription from fungi yeast
- C12N2830/704—S. cerevisiae
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/82—Subcellular parts of microorganisms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/948—Microorganisms using viruses or cell lines
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/974—Aids related test
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/826—Viruses
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66750184A | 1984-10-31 | 1984-10-31 | |
US69653485A | 1985-01-30 | 1985-01-30 | |
US77344785A | 1985-09-06 | 1985-09-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE10399037I2 true DE10399037I2 (de) | 2004-05-06 |
Family
ID=27418170
Family Applications (7)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE200512000031 Pending DE122005000031I1 (de) | 1984-10-31 | 1985-10-30 | Rekombinante Proteine von mit Lymphadenopathiesyndrom und/oder erworbenem Immunschw{chesyndrom assoziierten Viren. |
DE3588253T Expired - Lifetime DE3588253T2 (de) | 1984-10-31 | 1985-10-30 | Rekombinante Proteine von mit Lymphadenopathiesyndrom und/oder erworbenem Immunschwächesyndrom assoziierten Viren |
DE2003199037 Active DE10399037I2 (de) | 1984-10-31 | 1985-10-30 | Rekombinante Virusproteine begleitet von lymphadenopathischem Sydrom und/oder "Acquired Immune Deficiency Syndrome" (AIDS). |
DE3587394T Expired - Lifetime DE3587394T3 (de) | 1984-10-31 | 1985-10-30 | Rekombinante Virusproteine begleitet von lymphadenopathischem Syndrom und/oder "Acquired Immune Deficiency Syndrome" (AIDS). |
DE1245678T Pending DE1245678T1 (de) | 1984-10-31 | 1985-10-30 | Rekombinante Proteine von mit Lymphadenopathiesyndrom und/oder erworbenem Immunschwächesyndrom assoziierten Viren |
DE3588252T Expired - Lifetime DE3588252T2 (de) | 1984-10-31 | 1985-10-30 | Rekombinante Proteine von mit Lymphadenopathiesyndrom und/oder erworbenem Immunschwächesyndrom assoziierten Viren |
DE19853587394 Pending DE10399037I1 (de) | 1984-10-31 | 1985-10-30 | Rekombinante Virusproteine begleitet von lymphadenopathischem Syndrom und/oder "Acquired Immune Deficiency Syndrome" (AIDS) |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE200512000031 Pending DE122005000031I1 (de) | 1984-10-31 | 1985-10-30 | Rekombinante Proteine von mit Lymphadenopathiesyndrom und/oder erworbenem Immunschw{chesyndrom assoziierten Viren. |
DE3588253T Expired - Lifetime DE3588253T2 (de) | 1984-10-31 | 1985-10-30 | Rekombinante Proteine von mit Lymphadenopathiesyndrom und/oder erworbenem Immunschwächesyndrom assoziierten Viren |
Family Applications After (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE3587394T Expired - Lifetime DE3587394T3 (de) | 1984-10-31 | 1985-10-30 | Rekombinante Virusproteine begleitet von lymphadenopathischem Syndrom und/oder "Acquired Immune Deficiency Syndrome" (AIDS). |
DE1245678T Pending DE1245678T1 (de) | 1984-10-31 | 1985-10-30 | Rekombinante Proteine von mit Lymphadenopathiesyndrom und/oder erworbenem Immunschwächesyndrom assoziierten Viren |
DE3588252T Expired - Lifetime DE3588252T2 (de) | 1984-10-31 | 1985-10-30 | Rekombinante Proteine von mit Lymphadenopathiesyndrom und/oder erworbenem Immunschwächesyndrom assoziierten Viren |
DE19853587394 Pending DE10399037I1 (de) | 1984-10-31 | 1985-10-30 | Rekombinante Virusproteine begleitet von lymphadenopathischem Syndrom und/oder "Acquired Immune Deficiency Syndrome" (AIDS) |
Country Status (9)
Country | Link |
---|---|
US (5) | US5156949A (de) |
EP (3) | EP1245678B1 (de) |
JP (7) | JP2865283B2 (de) |
AT (3) | ATE295881T1 (de) |
CA (2) | CA1341423C (de) |
DE (7) | DE122005000031I1 (de) |
HK (1) | HK102495A (de) |
LU (1) | LU91049I2 (de) |
NL (2) | NL300137I2 (de) |
Families Citing this family (140)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE95236T1 (de) * | 1983-04-25 | 1993-10-15 | Chiron Corp | Hybrid-dns-synthesis von reifen insulinaehnlichen wachstumsfaktoren. |
GB8429099D0 (en) * | 1984-11-16 | 1984-12-27 | Pasteur Institut | Closed dna sequences |
US7217508B1 (en) | 1983-09-15 | 2007-05-15 | Institut Pasteur | Cloned DNA sequence related to genomic RNA of human immunodeficiency virus (HIV-1) |
US6600023B1 (en) | 1983-09-15 | 2003-07-29 | Institut Pasteur | Antibody directed against HIV-1 P25 antigen |
US7205102B1 (en) | 1983-09-15 | 2007-04-17 | Institut Pasteur | Cloned DNA sequences related to the genomic RNA of lymphadenopathy-associated virus (LAV) and proteins encoded by said LAV genomic RNA |
US6395495B1 (en) | 1983-09-15 | 2002-05-28 | Institut Pasteur | Methods and kits for detecting antibodies against an HIV variant |
GB8423659D0 (en) | 1984-09-19 | 1984-10-24 | Pasteur Institut | Cloned dna sequences |
US6428952B1 (en) * | 1983-09-15 | 2002-08-06 | Institut Pasteur | Methods and kits employing LAV antigens for the detection of HIV-1-specific antibodies |
US5217861A (en) * | 1983-09-15 | 1993-06-08 | Institut Pasteur | Antigen of a human retrovirus, namely p18 protein of human immunodeficiency virus (HIV), compositions containing the antigen, a diagnostic method for detecting acquired immune deficiency syndrome (AIDS) and pre-AIDS and a kit therefor |
US7232654B1 (en) | 1983-09-15 | 2007-06-19 | Institut Pasteur | DNA sequence of the LTR region of human immunodeficiency virus type 1 (HIV-1) |
US7351412B1 (en) | 1983-12-05 | 2008-04-01 | Institut Pasteur | Cloned DNA sequences related to the genomic RNA of lymphadenopathy-associated-virus (LAV) and proteins encoded by said LAV genomic RNA |
EP0480480A3 (en) * | 1984-05-11 | 1992-06-10 | Chiron Corporation | Enhanced yeast transcription employing hybrid promoter region constructs |
US6858712B1 (en) * | 1984-08-22 | 2005-02-22 | The United States Of America As Represented By The Department Of Health And Human Services | Cloning and expression of HTLV-III DNA |
US9309574B1 (en) | 1984-08-22 | 2016-04-12 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Molecular cloning of HIV-1 from immortalized cell lines |
US9328391B1 (en) | 1984-08-22 | 2016-05-03 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Cloning and expression of HIV-1 DNA |
US7045130B1 (en) | 1984-10-18 | 2006-05-16 | Institut Pasteur | Antibodies against antigens of human immunodeficiency virus (HIV-1) |
ATE373010T1 (de) * | 1984-10-18 | 2007-09-15 | Pasteur Institut | Gag-antigen und dessen verwendung zum nachweis von lav-infektion, sowie in immunogenen zusammensetzungen |
US5705612A (en) | 1984-10-18 | 1998-01-06 | Institut Pasteur And Centre National De La Recherche Scientifique | NEF peptide encoded by human immunodefiency virus type 1 (HIV-1) |
US7273695B1 (en) | 1984-10-31 | 2007-09-25 | Novartis Vaccines And Diagnostics, Inc. | HIV immunoassays using synthetic envelope polypeptides |
US7285271B1 (en) | 1984-10-31 | 2007-10-23 | Novartis Vaccines And Diagnostics, Inc. | Antigenic composition comprising an HIV gag or env polypeptide |
CA1341423C (en) * | 1984-10-31 | 2003-03-04 | Paul A. Luciw | Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome |
US6894152B1 (en) | 1984-11-16 | 2005-05-17 | Institut Pasteur | Cloned DNA sequences related to the genomic RNA of lymphadenopathy-associated-virus (LAV) and proteins encoded by said LAV genomic RNA |
US6534285B1 (en) * | 1984-12-24 | 2003-03-18 | Genentech, Inc. | Molecularly cloned acquired immunodeficiency syndrome polypeptides and their methods of use |
EP0220234B1 (de) * | 1985-04-08 | 1994-08-03 | Genetic Systems Corporation | EXPRESSION UND DIAGNOSE MIT gag-KODIERTEN PEPTIDEN, DIE MIT ANTIKÖRPERN GEGEN LAV IMMUNOLOGISCH REAKTIV SIND |
JP2869063B2 (ja) * | 1985-04-08 | 1999-03-10 | ジエネテイツク システムズ コ−ポレイシヨン | LAVに対する抗体と免疫的に反応性であるgagによりコードされたペプチドの発現及び使用 |
IE64785B1 (en) * | 1985-04-08 | 1995-09-06 | Genetic Systems Corp | Expression of immunologically reactive viral proteins |
NZ215867A (en) * | 1985-04-19 | 1989-10-27 | Hoffmann La Roche | Aids envelope protein, dna vectors and method of production |
US5773210A (en) * | 1985-04-19 | 1998-06-30 | The United States Of America As Represented By The Department Of Health And Human Services | Acquired immune deficiency syndrome (AIDS) viral envelope protein and method of testing for AIDS |
US4629783A (en) * | 1985-04-29 | 1986-12-16 | Genetic Systems Corporation | Synthetic antigen for the detection of AIDS-related disease |
JP2564268B2 (ja) * | 1985-08-28 | 1996-12-18 | 協和醗酵工業株式会社 | 融合抗原ポリペプチド |
FR2593519B1 (fr) * | 1985-09-25 | 1994-01-07 | Oncogen | Vaccin contre le syndrome immunodeficitaire acquis et intermediaires pour la preparation de ce vaccin |
NZ217645A (en) * | 1985-09-25 | 1991-11-26 | Oncogen | Recombinant viruses expressing lav/htlv-iii related epitopes and vaccine formulations |
ES2054616T3 (es) * | 1985-12-17 | 1994-08-16 | Akzo Nv | Reactivo inmunoquimico. |
DE3674555D1 (de) * | 1985-12-20 | 1990-10-31 | Abbott Lab | Immuntest fuer antikoerper gegen htlv-iii. |
EP0230222A1 (de) * | 1986-01-06 | 1987-07-29 | F. Hoffmann-La Roche Ag | Expression des HTLV-III Gag-Gens |
US4734362A (en) * | 1986-02-03 | 1988-03-29 | Cambridge Bioscience Corporation | Process for purifying recombinant proteins, and products thereof |
US4808536A (en) * | 1986-02-27 | 1989-02-28 | Centocor, Inc. | Immunochemical method for detection of antibody against HTLV-III core protein based upon recombinant HTLV-III gag gene encoded protein |
US5075211A (en) * | 1986-03-26 | 1991-12-24 | Genetic Systems Corporation | Synthetic antigen for the detection of AIDS-related disease |
US4925784A (en) * | 1986-04-04 | 1990-05-15 | Hoffmann-La Roche Inc. | Expression and purification of an HTLV-III gag/env gene protein |
US4983387A (en) * | 1986-05-19 | 1991-01-08 | Viral Technologies Inc. | HIV related peptides, immunogenic antigens, and use therefor as subunit vaccine for AIDS virus |
US5017688A (en) * | 1986-06-12 | 1991-05-21 | Biogen, Inc. | Peptides involved in the pathogenesis of HIV infection |
US4943627A (en) * | 1986-06-12 | 1990-07-24 | Biogen, Inc. | Peptides involved in the pathogenesis of HIV infection |
US5034511A (en) | 1987-04-13 | 1991-07-23 | Institut Pasteur | Variant of LAV viruses |
EP0525828A3 (en) * | 1986-08-01 | 1993-02-24 | Repligen Corporation | Recombinant polypeptides and their uses, including assay for aids virus |
US5166050A (en) * | 1986-08-20 | 1992-11-24 | Bristol-Myers Squibb Company | Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections |
NZ221440A (en) * | 1986-08-20 | 1991-11-26 | Genetic Systems Corp | Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections |
DE3636540A1 (de) * | 1986-10-27 | 1988-04-28 | Behringwerke Ag | Verfahren zur bestimmung von anti-hiv, mittel dazu und ihre verwendung in diesem verfahren |
SE8701628D0 (sv) * | 1987-04-16 | 1987-04-16 | Erling Norrby | Medel for analys mm |
EP0293792A3 (de) * | 1987-06-01 | 1990-01-17 | The Du Pont Merck Pharmaceutical Company | Von menschlichem Immunmangelvirus GAG-kodierte Proteine |
US5679399A (en) * | 1987-07-17 | 1997-10-21 | Bio Barrier, Inc. | Method of forming a membrane, especially a latex or polymer membrane, including multiple discrete layers |
US5549924A (en) * | 1987-07-17 | 1996-08-27 | Robin Renee Thill Shlenker | Method of forming a membrane, especially a latex or polymer membrane, including a deactivating barrier and indicating layer |
US5447837A (en) * | 1987-08-05 | 1995-09-05 | Calypte, Inc. | Multi-immunoassay diagnostic system for antigens or antibodies or both |
US5118602A (en) * | 1987-08-26 | 1992-06-02 | The Regents Of The University Of California | Feline T-lymphotropic lentivirus assay |
IE63455B1 (en) * | 1987-09-04 | 1995-04-19 | Int Murex Tech Corp | Immunoassay and biological constructs for use therein |
JPS6474990A (en) * | 1987-09-17 | 1989-03-20 | Susumu Maeda | Vector, recombinant dna, virus and production of protein |
DK643188A (da) * | 1987-11-24 | 1989-05-25 | Smithkline Biolog | Ekspression af hiv-proteiner i e.coli og s.cerevisiae |
US7442525B1 (en) | 1987-12-24 | 2008-10-28 | Novartis Vaccines And Diagnostics, Inc. | Method for expressing HIV polypeptides |
US5322769A (en) * | 1988-03-11 | 1994-06-21 | Abbott Laboratories | Methods for using CKS fusion proteins |
US5204259A (en) * | 1988-05-06 | 1993-04-20 | Pharmacia Genetic Engineering, Inc. | Methods and systems for producing HIV antigens |
FR2635532B1 (fr) * | 1988-07-29 | 1992-05-22 | Pasteur Institut | Particules hbsag recombinantes hybrides : caracteristiques morphologiques de l'antigene hbsag contenant 1 sequence immunogene induisant des anticorps neutralisants diriges contre hiv ou susceptible d'etre reconnue par de tels anticorps; sequences nucleotidiques codant pour de telles particules; vaccins les contenant |
DE68918867T2 (de) * | 1988-09-13 | 1995-02-16 | Chiron Corp | Mutanten des hiv-1 Hüllproteins mit fehlenden hypervariabelen domänen. |
US5656458A (en) * | 1988-11-04 | 1997-08-12 | Chiron Corporation | Expression and processing of amino terminus acetylated FGF's in yeast |
CA2003383A1 (en) * | 1988-11-23 | 1990-05-23 | Sushil G. Devare | Synthetic dna derived recombinant hiv antigens |
ATE113989T1 (de) * | 1989-02-03 | 1994-11-15 | Abbott Lab | Monoklonaler antikörper zur unterscheidung hiv-2- seropositiver von hiv-1-seropositiven individuen. |
US6589734B1 (en) * | 1989-07-11 | 2003-07-08 | Gen-Probe Incorporated | Detection of HIV |
US5856088A (en) * | 1989-07-11 | 1999-01-05 | Gen-Probe Incorporated | Detection of human immunodeficiency virus type 1 |
US6337209B1 (en) | 1992-02-26 | 2002-01-08 | Glaxo Wellcome Inc. | Molecular constructs containing a carcinoembryonic antigen regulatory sequence |
PL172133B1 (pl) † | 1990-04-04 | 1997-08-29 | Chiron Corp | Sposób tworzenia kombinacji antygenów wirusowego zapalenia watroby typu C (HCV) i sposób wykrywania przeciwcial przeciw wirusowemu zapaleniu watroby typu C (HCV) PL PL PL PL PL PL |
AU9028791A (en) * | 1990-10-05 | 1992-04-28 | President And Fellows Of Harvard College | Detection and isolation of ligands |
US5773211A (en) * | 1991-07-10 | 1998-06-30 | Abbott Laboratories | Differentiation of HTLV-I and HTLV-II using synthetic peptides |
US6352826B1 (en) * | 1991-11-25 | 2002-03-05 | Yoreh Biotechnologies, Ltd. | Method and kit for the detection of retroviral specific antibodies in seronegative individuals |
ES2164071T3 (es) * | 1992-03-27 | 2002-02-16 | Abbott Lab | Control de verificacion de dosificado para metodos de analisis. |
ES2126620T5 (es) * | 1992-10-06 | 2010-05-21 | Siemens Healthcare Diagnostics Products Gmbh | Retrovirus del grupo de los vih y su utilizacion. |
AU686616B2 (en) | 1993-03-26 | 1998-02-12 | Gen-Probe Incorporated | Detection of human immunodeficiency virus type 1 |
US6479055B1 (en) | 1993-06-07 | 2002-11-12 | Trimeris, Inc. | Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission |
US20070202127A1 (en) * | 1993-06-07 | 2007-08-30 | Duke University | Nucleic acids encoding DP-178 and other viral fusion inhibitor peptides useful for treating aids |
US6074646A (en) * | 1993-10-26 | 2000-06-13 | Board Of Regents, The University Of Texas System | Nondenatured HIV envelope antigens for detecting early HIV-specific antibodies |
CA2178635C (en) * | 1993-12-10 | 2004-05-25 | Yu-Wen Hu | Immunofluorescence assay for the detection of antibodies using recombinant antigens in insoluble form |
US5695928A (en) * | 1993-12-10 | 1997-12-09 | Novartis Corporation | Rapid immunoassay for detection of antibodies or antigens incorporating simultaneous sample extraction and immunogenic reaction |
DE4405810A1 (de) | 1994-02-23 | 1995-08-24 | Behringwerke Ag | Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung |
US6319665B1 (en) | 1994-06-07 | 2001-11-20 | Inverness Medical Technology, Inc. | Home test kit and method with telephone verification of results |
WO1998015658A1 (en) | 1996-10-10 | 1998-04-16 | Probe International | Compositions and methods for treating viral infections |
US6392029B1 (en) * | 1997-05-09 | 2002-05-21 | The Research Foundation Of State University Of New York | HIV chemokines |
US8765461B2 (en) | 1997-05-09 | 2014-07-01 | Linda B. Ludwig | HIV antisense proteins |
US20030118985A1 (en) * | 1997-05-14 | 2003-06-26 | Hunt Jeffrey C. | Mouse monoclonal antibody (5-21-3) to human immunodeficiency virus gp41 protein |
US5962665A (en) | 1997-06-16 | 1999-10-05 | Abbott Laboratories | Nucleic acid primers and probes for detecting HIV-1 and HIV-2 |
US6846905B2 (en) * | 1997-08-15 | 2005-01-25 | Abbott Laboratories | Antigen constructs useful in the detection and differentiation of antibodies to HIV |
KR20000006334A (ko) * | 1998-06-26 | 2000-01-25 | 이선경 | 바이러스코딩염기서열이전혀없는고효율레트로바이러스벡터 |
US7935805B1 (en) | 1998-12-31 | 2011-05-03 | Novartis Vaccines & Diagnostics, Inc | Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof |
US6689879B2 (en) | 1998-12-31 | 2004-02-10 | Chiron Corporation | Modified HIV Env polypeptides |
EP1141313A2 (de) | 1998-12-31 | 2001-10-10 | Chiron Corporation | Verbesserte exprimierung von hiv polypeptiden und herstellung von virusähnliche partikeln |
WO2000039304A2 (en) * | 1998-12-31 | 2000-07-06 | Chiron Corporation | Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
CA2689696C (en) | 1999-02-26 | 2013-08-06 | Novartis Vaccines And Diagnostics, Inc. | Microemulsions with adsorbed macromolecules and microparticles |
US6235479B1 (en) | 1999-04-13 | 2001-05-22 | Bio Merieux, Inc. | Methods and devices for performing analysis of a nucleic acid sample |
AU4366000A (en) | 1999-04-14 | 2000-11-14 | Chiron Corporation | Compositions and methods for generating an immune response utilizing alphavirus-based vector systems |
WO2001056355A2 (en) | 2000-02-04 | 2001-08-09 | Duke University | Human immunodeficiency virus vaccine |
WO2002000897A2 (en) | 2000-06-23 | 2002-01-03 | Maxygen, Inc. | Novel chimeric promoters |
CA2835978C (en) | 2000-09-01 | 2016-10-11 | Gen-Probe Incorporated | Amplification of hiv-1 sequences for detection of sequences associated with drug-resistance mutations |
CN1247785C (zh) * | 2000-10-13 | 2006-03-29 | 希龙公司 | 巨细胞病毒内含子a片段 |
US6818392B2 (en) * | 2000-12-06 | 2004-11-16 | Abbott Laboratories | Monoclonal antibodies to human immunodeficiency virus and uses thereof |
WO2002079470A1 (en) * | 2001-03-30 | 2002-10-10 | King A Christie | Disease-specific promoter chimeras for gene expression |
CA2458995C (en) * | 2001-08-31 | 2013-04-30 | Chiron Corporation | Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof |
EP1444521A4 (de) * | 2001-09-17 | 2006-12-06 | Univ Texas | Verfahren und zusammensetzungen unter beteiligung von thymidinphosphorylase als marker für hiv-infektion, den verlauf von aids und arzneistoffresistenz |
AR045702A1 (es) | 2001-10-03 | 2005-11-09 | Chiron Corp | Composiciones de adyuvantes. |
US20060115814A1 (en) * | 2002-02-28 | 2006-06-01 | Cloyd Miles W | Methods and compositions, relating to hiv gp41 antigens and other hiv envelope antigens |
WO2005061734A2 (en) * | 2003-12-03 | 2005-07-07 | Abbott Laboratories | Double stranded linear nucleic acid probe and uses thereof |
US7888003B2 (en) | 2004-09-08 | 2011-02-15 | The United States Of America As Represented By The Department Of Health And Human Services | Methods for the detection of HIV-1 antibodies employing polypeptides obtained from gag P6 protein |
US20060068380A1 (en) * | 2004-09-30 | 2006-03-30 | Gen-Probe Incorporated | Assay for detecting and quantifying HIV-1 |
US20080282331A1 (en) * | 2004-10-08 | 2008-11-13 | Advanced Network Technology Laboratories Pte Ltd | User Provisioning With Multi-Factor Authentication |
WO2007070372A2 (en) * | 2005-12-09 | 2007-06-21 | Entremed, Inc. | Compositions and methods for inhibiting cellular proliferation |
GB0701253D0 (en) | 2007-01-23 | 2007-02-28 | Diagnostics For The Real World | Nucleic acid amplification and testing |
US20080299624A1 (en) * | 2007-06-01 | 2008-12-04 | Edward Heslop | Continuous fermentation apparatus and method |
ES2316302B1 (es) * | 2007-09-27 | 2010-01-26 | Fundacion Reina Mercedes Para La Investigacion Sanitaria | Metodo de analisis inmunologico, su utilizacion y kit para su realizacion. |
EP2612868B1 (de) | 2007-11-01 | 2018-08-15 | Astellas Pharma Inc. | Immunsuppressive Polypeptide und Nucleinsäuren |
US8980546B2 (en) | 2009-05-21 | 2015-03-17 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Method for the detection of HIV-1-specific antibodies utilizing a Vpu polypeptide |
EP2451475A2 (de) | 2009-07-06 | 2012-05-16 | Novartis AG | Selbstreplizierende rna-moleküle und ihre verwendung |
US10113206B2 (en) | 2010-02-24 | 2018-10-30 | Grifols Therapeutics Inc. | Methods, compositions, and kits for determining human immunodeficiency virus (HIV) |
CA2793959C (en) | 2010-03-25 | 2019-06-04 | Oregon Health & Science University | Cmv glycoproteins and recombinant vectors |
MX343410B (es) | 2010-07-06 | 2016-11-04 | Novartis Ag * | Emulsiones cationicas de agua en aceite. |
CA2832109C (en) | 2011-06-10 | 2021-07-06 | Oregon Health & Science University | Cmv glycoproteins and recombinant vectors |
JP6120839B2 (ja) | 2011-07-06 | 2017-04-26 | ノバルティス アーゲー | カチオン性水中油型エマルジョン |
EP3424495A1 (de) | 2011-07-06 | 2019-01-09 | GlaxoSmithKline Biologicals S.A. | Öl-in-wasser-emulsionen mit nukleinsäuren |
EP2568289A3 (de) | 2011-09-12 | 2013-04-03 | International AIDS Vaccine Initiative | Immunselektion von rekombinantem vesikulärem Stomatitisvirus mit Expression von HIV-1-Proteinen durch Breitbandneutralisierungs-Antikörper |
BR112014008694A2 (pt) | 2011-10-11 | 2017-06-20 | Novartis Ag | moléculas de ácido nucleico policistrônico recombinante |
US9402894B2 (en) | 2011-10-27 | 2016-08-02 | International Aids Vaccine Initiative | Viral particles derived from an enveloped virus |
SG10201603896RA (en) | 2012-05-04 | 2016-07-28 | Pfizer | Prostate-associated antigens and vaccine-based immunotherapy regimens |
ES2631608T3 (es) | 2012-06-27 | 2017-09-01 | International Aids Vaccine Initiative | Variante de la glicoproteína Env del VIH-1 |
CN105228649B (zh) | 2013-03-14 | 2019-01-18 | 雅培制药有限公司 | Hcv抗原-抗体组合测定和方法以及用在其中的组合物 |
US9790478B2 (en) | 2013-03-14 | 2017-10-17 | Abbott Laboratories | HCV NS3 recombinant antigens and mutants thereof for improved antibody detection |
EP3564384A1 (de) | 2013-03-14 | 2019-11-06 | Abbott Laboratories | Monoklonale antikörper gegen hcv-core lipid-bindender domäne |
US20150065381A1 (en) | 2013-09-05 | 2015-03-05 | International Aids Vaccine Initiative | Methods of identifying novel hiv-1 immunogens |
EP2873423B1 (de) | 2013-10-07 | 2017-05-31 | International Aids Vaccine Initiative | Lösliche hiv-1-hüllglykoproteintrimere |
US10174292B2 (en) | 2015-03-20 | 2019-01-08 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
US9931394B2 (en) | 2015-03-23 | 2018-04-03 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
TWI654302B (zh) | 2016-01-19 | 2019-03-21 | 輝瑞股份有限公司 | 癌症疫苗 |
US11261462B2 (en) | 2016-01-27 | 2022-03-01 | Just-Evotec Biologics, Inc. | Inducible expression from transposon-based vectors and uses |
US11028410B2 (en) | 2016-01-27 | 2021-06-08 | Just-Evotec Biologics, Inc. | Hybrid promoter and uses thereof |
US11098310B2 (en) | 2016-01-27 | 2021-08-24 | Just-Evotec Biologics, Inc. | Expression from transposon-based vectors and uses |
IT201600116554A1 (it) * | 2016-11-17 | 2018-05-17 | Fond Ri Med | Probiotic yeasts as novel vaccination vectors |
CN111065408A (zh) | 2017-07-11 | 2020-04-24 | 辉瑞公司 | 免疫原性组合物 |
Family Cites Families (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA443605A (en) | 1947-08-12 | Forrest David | Surface grinder | |
IE52036B1 (en) | 1979-05-24 | 1987-05-27 | Univ California | Non-passageable viruses |
NZ199722A (en) | 1981-02-25 | 1985-12-13 | Genentech Inc | Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain |
EP0062574A3 (de) | 1981-03-31 | 1982-12-29 | The Regents Of The University Of California | Synthese von Virusproteinen |
FR2506904A1 (fr) | 1981-05-29 | 1982-12-03 | Applic Catalytiques Ste Ly | Procede de regulation d'une installation de chauffage et dispositif pour sa mise en oeuvre |
DK368882A (da) | 1981-08-25 | 1983-02-26 | Alan John Kingsman | Expessions vektorer |
NZ201705A (en) | 1981-08-31 | 1986-03-14 | Genentech Inc | Recombinant dna method for production of hepatitis b surface antigen in yeast |
US4775622A (en) | 1982-03-08 | 1988-10-04 | Genentech, Inc. | Expression, processing and secretion of heterologous protein by yeast |
US4468382A (en) | 1982-07-15 | 1984-08-28 | New England Medical Center, Inc. | Polypeptide-toxin hybrid protein |
DE3382547D1 (de) | 1983-01-12 | 1992-05-27 | Chiron Corp | Sekretorische expression in eukaryoten. |
US4797359A (en) * | 1983-05-10 | 1989-01-10 | Board Of Regents, The University Of Texas System | Heat shock regulated production of selected and fused proteins in yeast |
EP0136798A3 (de) * | 1983-08-25 | 1986-02-19 | Biotech Research Laboratories Inc. | Titrierungsplatte und Testsatz zum Nachweis von Antikörpern in menschlichem Serum und ihre Herstellung und Verwendung |
US5173400A (en) * | 1983-09-15 | 1992-12-22 | Institut Pasteur | Antibody detection of antibodies to viral proteins in serum |
GB8423659D0 (en) * | 1984-09-19 | 1984-10-24 | Pasteur Institut | Cloned dna sequences |
FR2571968B1 (fr) * | 1984-10-18 | 1989-03-17 | Pasteur Institut | Virus purifie des lymphadenopathies et du syndrome d'immuno-depression acquise et antigenes d'enveloppe de ce virus, procede d'obtention de ce virus et de ces antigenes d'enveloppe de ce virus, applications de ce virus ou de ces antigenes a la preparation de compositions immunogenes ou pour le diagnostic des susdites affections. |
GB8324800D0 (en) * | 1983-09-15 | 1983-10-19 | Pasteur Institut | Antigens |
JPS6061534A (ja) * | 1983-09-16 | 1985-04-09 | Kyowa Hakko Kogyo Co Ltd | 成人t細胞白血病ウイルス抗原ペプチド |
US4519857A (en) | 1983-10-05 | 1985-05-28 | Natmar, Inc. | Elastic band sealer apparatus and method for forming a continuous non-overlapping band |
US5374519A (en) * | 1983-12-05 | 1994-12-20 | Institut Pasteur | Oligopeptides comprising p18 protein of human immunodeficiency virus (HIV), compositions comprising peptides of p18 protein of HIV, and diagnostic kits and methods for detecting acquired immune deficiency syndrome (AIDS) |
US4740461A (en) * | 1983-12-27 | 1988-04-26 | Genetics Institute, Inc. | Vectors and methods for transformation of eucaryotic cells |
EP0152030A3 (de) * | 1984-02-03 | 1986-08-13 | Juridical Foundation Japanese Foundation for Cancer Research | Adult-T-Zell-Leukemiavirus-Antigenpolypeptid |
US4618578A (en) * | 1984-07-17 | 1986-10-21 | Chiron Corporation | Expression of glycoprotein D of herpes simplex virus |
US4652599A (en) * | 1984-04-23 | 1987-03-24 | The United States Of America As Represented By The Department Of Health And Human Services | Method of continuous production of retroviruses (HTLV-III) from patients with AIDS and pre-AIDS using permissive cells |
CA1247005A (en) * | 1984-04-23 | 1988-12-20 | Robert C. Gallo | Isolation of protein of htlv-iii, serological detection of antibodies to htlv-iii in sera of patients with aids and pre-aids conditions, and detection of htlv-iii infection by immuno-assays using htlv-iii and its proteins |
US4520113A (en) * | 1984-04-23 | 1985-05-28 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Serological detection of antibodies to HTLV-III in sera of patients with AIDS and pre-AIDS conditions |
JPS60226658A (ja) * | 1984-04-25 | 1985-11-11 | Matsushita Electric Works Ltd | 加熱器 |
US4738922A (en) * | 1984-05-25 | 1988-04-19 | Dana Farber Cancer Institute | Trans-acting transcriptional factors |
US4716102A (en) * | 1984-08-15 | 1987-12-29 | Regents Of The University Of California | Purified AIDS-associated virus ARV-2 |
US9328391B1 (en) * | 1984-08-22 | 2016-05-03 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Cloning and expression of HIV-1 DNA |
IL76082A (en) * | 1984-08-22 | 1991-07-18 | Us Health | Molecular clones of the genome of htlv-iii and a process for the preparation thereof |
DE3431140A1 (de) * | 1984-08-24 | 1986-03-06 | Behringwerke Ag, 3550 Marburg | Enhancer fuer eukaryotische expressionssysteme |
JPS6226300A (ja) * | 1984-10-10 | 1987-02-04 | セントコ−・インコ−ポレ−テツド | Htlv−3dnaのクロ−ニングおよび発現 |
ATE373010T1 (de) * | 1984-10-18 | 2007-09-15 | Pasteur Institut | Gag-antigen und dessen verwendung zum nachweis von lav-infektion, sowie in immunogenen zusammensetzungen |
CA1341423C (en) | 1984-10-31 | 2003-03-04 | Paul A. Luciw | Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome |
US4725669A (en) * | 1984-11-09 | 1988-02-16 | President And Fellows Of Harvard College | Assay for detecting infection by human T-cell lymphotropic virus-III |
DE3588134T2 (de) | 1984-12-24 | 1997-03-20 | Genentech Inc | Fusionen von AIDS-verwandten Polypeptiden |
US5168062A (en) * | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
US4751180A (en) * | 1985-03-28 | 1988-06-14 | Chiron Corporation | Expression using fused genes providing for protein product |
US4629783A (en) * | 1985-04-29 | 1986-12-16 | Genetic Systems Corporation | Synthetic antigen for the detection of AIDS-related disease |
EP0220273B2 (de) | 1985-04-29 | 2007-01-17 | Bio-Rad Laboratories, Inc. | Synthetische antigene zum nachweis von aids |
AU603768B2 (en) * | 1985-07-04 | 1990-11-29 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Lymphotoxin dna, lymphotoxin expression vector, lymphotoxin resistant cell, transformant with lymphotoxin expression vector and process for preparing lymphotoxin |
US5175098A (en) * | 1985-08-07 | 1992-12-29 | Genetic Systems Corporation | Expression and diagnostic use of gag encoded peptides which are immunologically reactive with antibodies to HIV |
US5306614A (en) * | 1986-01-22 | 1994-04-26 | Institut Pasteur | Methods and kits for diagnosing human immunodeficiency virus type 2(HIV-2) |
US5310651A (en) * | 1986-01-22 | 1994-05-10 | Institut Pasteur | DNA probes of human immunodeficiency virus type 2 (HIV-2), and methods employing these probes for dectecting the presence of HIV-2 |
US5066782A (en) * | 1986-01-22 | 1991-11-19 | Institut Pasteur | Retrovirus capable of causing AIDS, means and method for detecting it in vitro |
US5079342A (en) * | 1986-01-22 | 1992-01-07 | Institut Pasteur | Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and use of these DNA clones and polypeptides in diagnostic kits |
US4806463A (en) * | 1986-05-23 | 1989-02-21 | Worcester Foundation For Experimental Biology | Inhibition of HTLV-III by exogenous oligonucleotides |
IE872455L (en) * | 1986-09-12 | 1988-03-12 | Lanstrase Ltd | Improved recombinant expression |
US5024939A (en) * | 1987-07-09 | 1991-06-18 | Genentech, Inc. | Transient expression system for producing recombinant protein |
GB8717430D0 (en) * | 1987-07-23 | 1987-08-26 | Celltech Ltd | Recombinant dna product |
US5169753A (en) * | 1989-06-05 | 1992-12-08 | Genelabs Incorporated | Method and kit for detecting human retrovirus |
DK0554389T4 (da) * | 1990-10-17 | 2002-11-11 | Us Health | Molekylære kloner af HIV-1 og anvendelse deraf |
-
1985
- 1985-10-28 CA CA000494006A patent/CA1341423C/en not_active Expired - Lifetime
- 1985-10-28 CA CA000617159A patent/CA1341482C/en not_active Expired - Lifetime
- 1985-10-30 AT AT92201711T patent/ATE295881T1/de not_active IP Right Cessation
- 1985-10-30 DE DE200512000031 patent/DE122005000031I1/de active Pending
- 1985-10-30 DE DE3588253T patent/DE3588253T2/de not_active Expired - Lifetime
- 1985-10-30 DE DE2003199037 patent/DE10399037I2/de active Active
- 1985-10-30 DE DE3587394T patent/DE3587394T3/de not_active Expired - Lifetime
- 1985-10-30 DE DE1245678T patent/DE1245678T1/de active Pending
- 1985-10-30 DE DE3588252T patent/DE3588252T2/de not_active Expired - Lifetime
- 1985-10-30 AT AT85307860T patent/ATE90384T1/de active
- 1985-10-30 AT AT02077411T patent/ATE297468T1/de active
- 1985-10-30 EP EP02077411A patent/EP1245678B1/de not_active Revoked
- 1985-10-30 EP EP92201711A patent/EP0518443B1/de not_active Revoked
- 1985-10-30 EP EP85307860A patent/EP0181150B2/de not_active Expired - Lifetime
- 1985-10-30 DE DE19853587394 patent/DE10399037I1/de active Pending
- 1985-10-31 JP JP60246102A patent/JP2865283B2/ja not_active Expired - Lifetime
-
1987
- 1987-12-24 US US07/138,894 patent/US5156949A/en not_active Expired - Lifetime
-
1993
- 1993-06-28 US US08/083,391 patent/US6458527B1/en not_active Expired - Lifetime
-
1994
- 1994-08-10 US US08/288,336 patent/US5688688A/en not_active Expired - Lifetime
-
1995
- 1995-03-06 JP JP7045666A patent/JPH07311199A/ja active Pending
- 1995-03-06 JP JP7045602A patent/JPH07313184A/ja active Pending
- 1995-03-14 US US08/403,588 patent/US6531276B1/en not_active Expired - Lifetime
- 1995-05-17 US US08/442,750 patent/US7408053B1/en active Active
- 1995-06-22 HK HK102495A patent/HK102495A/xx not_active IP Right Cessation
-
1996
- 1996-11-25 JP JP8330391A patent/JPH09235297A/ja active Pending
-
1999
- 1999-04-22 JP JP11115582A patent/JPH11341992A/ja active Pending
-
2003
- 2003-10-22 JP JP2003362607A patent/JP2004081219A/ja not_active Withdrawn
- 2003-11-21 NL NL300137C patent/NL300137I2/nl unknown
- 2003-11-26 LU LU91049C patent/LU91049I2/fr unknown
-
2005
- 2005-03-01 JP JP2005056725A patent/JP2005137383A/ja active Pending
- 2005-06-08 NL NL300197C patent/NL300197I1/nl unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE10399037I2 (de) | Rekombinante Virusproteine begleitet von lymphadenopathischem Sydrom und/oder "Acquired Immune Deficiency Syndrome" (AIDS). | |
FI873141A0 (fi) | Daeggdjurs interleukin-4. | |
FI935808A0 (fi) | Hepatit-C-virus (HCV) polypeptider | |
RU94024561A (ru) | Иммунореактивные композиции, способ получения композиции, способы получения и обнаружения антител, набор днк, клетка-хозяин, способ получения белка | |
DZ467A1 (fr) | Interferon immunitaire urbain. | |
DE59504181D1 (de) | Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung | |
DE3650019D1 (de) | Expression von Virusproteinen mit immunologischer Aktivität. | |
ES2054743T3 (es) | Muteina de beta-galactosidasa enzimaticamente inactiva e inmunologicamente activa. | |
EA199900663A1 (ru) | Новые белки, связывающиеся с рецептором 1 интерферона, кодирующая их днк и способы модуляции клеточного ответа на интерфероны | |
ATE52798T1 (de) | Hepatitis-b-virus-gen enthaltendes rekombinantes plasmid, mit diesem rekombinanten plasmid transformierte hefe und herstellung von hepatitis-b-virus-oberflaechenantigen. |